Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|March 10, 2019
Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain MetastasesEriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori, et al.
Scientific Reports|April 1, 2024
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinomaYuko Iida, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.
Thoracic Cancer|April 14, 2022
Impact of losing adipose tissue on outcomes from PD-1/PD-L1 inhibitor monotherapy in non-small cell lung cancerNaoya Nishioka, Tateaki Naito, Taichi Miyawaki, et al.
Cancer Science|January 27, 2023
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weightYutaka Fujiwara, Reiko Makihara, Tetsunari Hase, et al.
JTO Clinical and Research Reports|September 30, 2021
Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLCTaichi Miyawaki, Tateaki Naito, Akihro Kodama, et al.
Oncotarget|May 1, 2018
Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapyNobuaki Mamesaya, Kazushige Wakuda, Katsuhiro Omae, et al.
International Journal of Clinical Oncology|January 8, 2021
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapyNobuaki Mamesaya, Koji Muramatsu, Michitoshi Yabe, et al.
Cancer Reports (Hoboken, N.J.)|September 9, 2024
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung CancerMeiko Morita, Akira Ono, Motoki Sekikawa, et al.
Thoracic Cancer|January 20, 2024
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancerYuko Iida, Kazushige Wakuda, Takuya Kawata, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2025
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002)Yoshimasa Shiraishi, Takayuki Shimose, Kazunori Tobino, et al.
Pageof 9